India is second highest testing for COVID-19


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ india-second-highest-testing-covid19
So far more than 28000 Indians have died due to coronavirus and 1.2 million have tested positive

The United States is driving the world as far as COVID-19 testing and India is at the second position, President Donald Trump said while reporting on his organization's reaction to the coronavirus pandemic.

So definitely more than 140,000 Americans have passed on due to coronavirus and 3.8 million have tried positive. While the US economy is gradually returning to ordinary, the pandemic is presently spreading in the Sun Belt of the nation.

"As one family, we grieve each valuable life that has been lost. I promise in their respect that we will build up immunization and we will overcome the infection. We're doing very well with immunization advancement and remedial turn of events," Trump said at a White House news gathering on Tuesday, his first on coronavirus following a little while.

Trump likewise said his organization will persevere relentlessly to spare lives and shield the helpless.

"We've found out such a great amount about this sickness. Also, we know who the powerless are, and we are going to in reality shield them," he said.

Trump guaranteed that the antibodies against the novel coronavirus will become a great deal sooner than anticipated.

Answering an inquiry, Trump said the US is "driving the world" as far as COVID-19 testing.

"We will be more than 50 million tests," he stated, including that "second nation is India with 12 million (tests). At that point you have 7,000,000, 6,000,000, and 4,000,000. I imagine that we are doing a gigantic measure of testing."

The "China infection", Trump stated, is a horrendous and perilous disease.

"It's a dreadful, terrible sickness that should've never been permitted to get away from China, however, it did. It tainted the world, and the world is languishing. Be that as it may, we' will get it dealt with, and we''re helping heaps of different nations," the US president said.

On handling the infection, Trump said his organization is building up an incredible technique.

"We've taken in a lot about it (COVID-19) and who it targets. We are building up a procedure that is' going to be extremely, amazing," he said.

"A few zones of our nation are doing quite well; others are doing less well. It will most likely, sadly, deteriorate before it shows signs of improvement," Trump said.

He said the middle age of the individuals who surrender to COVID-19 contamination is 78 years, including that generally 50% of the total of what passings have been people in nursing homes or long haul care.

"Youthful grown-ups may regularly have mellow or even no side effects. They won't realize they're wiped out. They won't have any thought that they have an infection. They won't have any thought whatsoever," he stated, including that adolescents will act dependably.

Trump said the information shows kids have the most minimal casualty hazard as 99.96 percent of all infection fatalities are grown-ups.

"By understanding these hazard profiles and figuring out how to treat the illness, we've had the option to incredibly lessen mortality in the United States," Trump said.

A few medicines are now accessible in the US that can essentially diminish the seriousness and length of the malady, including remdesivir, he said.

"We've learned accepted procedures for the treatment of the infection at each stage and have imparted these discoveries to clinical suppliers, and we've shared them everywhere throughout the world. The relationship with different nations has been solid. We''re all cooperating," Trump said.

Tags : #India #COVID-19 #Testing

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026